TruBridge Form 13G机构持股分析报告
Unlock More Features
Login to access AI-powered analysis, deep research reports and more advanced features

About us: Ginlix AI is the AI Investment Copilot powered by real data, bridging advanced AI with professional financial databases to provide verifiable, truth-based answers. Please use the chat box below to ask any financial question.
Related Stocks
Based on my research, I can provide a comprehensive analysis of the Form 13G filings for TruBridge and their implications for institutional investor sentiment and valuation.
Recent Schedule 13G filings reveal significant institutional investor activity in TruBridge, a healthcare technology solutions provider serving hospitals and healthcare systems. These passive investment disclosures collectively indicate substantial confidence from prominent investment firms [1][2][3].
Institutional Investor |
Ownership % |
Shares Held |
Filing Date |
Voting Power |
|---|---|---|---|---|
| Camac Partners, LLC (et al.) | 5.7% | 861,638 | Prior to Jan 2026 | Shared dispositive power |
| BlackRock, Inc. | 4.97% | 746,291 | Jan 21, 2026 (Amended) | 738,004 shares (sole) |
| The Vanguard Group | ~5.2% | 755,373 | Oct 17, 2025 | Not specified |
Note: As of September 30, 2025, BlackRock’s holdings were reported at 5.35% (777,761 shares) and Vanguard at 5.20% (755,373 shares) according to Investing.com data [4].
Form 13G filings are specifically designed for investors who acquire more than 5% of a company’s shares
- Camac Partners, LLC(along with Camac Capital, Camac Fund, and Eric Shahinian) explicitly filed under the passive investment provision, indicating no intention to seek board representation or operational control [1]
- BlackRock’samended 13G filing as of December 31, 2025, confirms their continued passive stance while maintaining substantial ownership [3]
- Multiple institutional investors filing 13G (rather than 13D) signals a conviction in the company’s long-term value propositionwithout activist intentions
The aggregate institutional ownership—particularly from firms like BlackRock and Vanguard—carries important sentiment implications:
- BlackRock(the world’s largest asset manager) holding nearly 5% represents a meaningful endorsement of TruBridge’s healthcare technology positioning
- Vanguard’s~5.2% stake further validates institutional confidence in the company’s sector and business model
- Combined with L6 Holdings’ 14.2% ownership (filed under 13D as an active investor) and Pinetree Capital’s 5.7% position, institutional ownership represents a substantial portion of float[5]
Despite positive institutional ownership signals, the stock has experienced pressure:
- Share price declined from $23.31 (January 24, 2025) to $20.65 (January 23, 2026), representing an 11.41% decline[6]
- This price weakness may have created an attractive entry pointfor value-oriented institutional investors
- The 13G filings suggest institutions view current levels as appropriate for passive, long-term positions
The institutional 13G filings may provide several valuation tailwinds:
Factor |
Impact |
|---|---|
| Legitimization | BlackRock/Vanguard endorsement validates the company’s fundamentals and growth trajectory |
| Reduced volatility | Stable institutional holdings typically decrease share price volatility |
| Analyst coverage | Major institutional ownership often attracts additional analyst attention |
| Lower cost of capital | Institutional validation may reduce perceived investment risk |
- Positive Signaling Effect: Other institutional investors may interpret BlackRock and Vanguard’s passive accumulation as a “quality stamp,” potentially attracting additional capital
- M&A Consideration: While 13G filers have passive intent, the aggregate ownership concentration (especially L6 Holdings’ 14.2% active 13D position) could make TruBridge amore attractive acquisition target[5]
- Activist Pressure Mitigation: The absence of 13D (active control-seeking) filings from major shareholders reduces concerns about activist intervention in the near term
- Price Decline Context: Despite institutional buying, the stock’s 11.41% year-over-year decline suggests underlying business or market concerns
- Passive = Not Bullish: Form 13G indicates investors are not actively advocating for changes; they may simply be maintaining diversified positions
- Future Selling Risk: If fundamentals deteriorate, passive investors can convert to active sellers without regulatory constraints
The concentration of Form 13G filings in early 2026 (particularly BlackRock’s January 21, 2026 amended filing and Vanguard’s October 2025 filing) suggests
- Steady Hand Strategy: Major institutions are maintaining positions rather than aggressively expanding, suggesting “hold” rather than “buy” sentiment at current levels
- Valuation Acceptance: Current price levels ($20.65 as of January 23, 2026) appear acceptable to sophisticated institutional investors
- Sector Thesis: Healthcare technology, particularly revenue cycle management and EHR solutions for hospitals, remains attractive to diversified institutional portfolios
The Form 13G filings for TruBridge reveal a
- Validationof TruBridge’s business model and market positioning
- Price supportat current levels from sophisticated, long-term oriented investors
- Increased visibilitythat may attract additional institutional attention
However, the passive nature of these filings means institutional investors are
[1] StreetInsider - Form SCHEDULE 13G TruBridge, Inc. Filed by: Camac Partners, LLC (https://www.streetinsider.com/SEC+Filings/Form+SCHEDULE+13G+TruBridge%2C+Inc.+Filed+by%3A+Camac+Partners%2C+LLC/25910402.html)
[2] StockTitan - TruBridge stake: Camac reports 5.7% ownership (https://www.stocktitan.net/sec-filings/TBRG/schedule-13g-tru-bridge-inc-passive-investment-disclosure-5-b0902c603fc4.html)
[3] StockTitan - BlackRock reports 4.97% TruBridge ownership stake (https://www.stocktitan.net/sec-filings/TBRG/schedule-13g-a-tru-bridge-inc-amended-passive-investment-disclosure-c47baf3ce69b.html)
[4] Investing.com - Who Owns Trubridge? TBRG Shareholders (https://in.investing.com/equities/computer-programs-ownership)
[5] StockTitan - TruBridge, L6 Holdings board cooperation pact (https://www.stocktitan.net/sec-filings/TBRG/schedule-13d-a-tru-bridge-inc-amended-major-shareholder-report-f73f0b6af2cd.html)
[6] Fintel - TBRG TruBridge Institutional Ownership (https://fintel.io/so/us/tbrg)
Insights are generated using AI models and historical data for informational purposes only. They do not constitute investment advice or recommendations. Past performance is not indicative of future results.
About us: Ginlix AI is the AI Investment Copilot powered by real data, bridging advanced AI with professional financial databases to provide verifiable, truth-based answers. Please use the chat box below to ask any financial question.